Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and biotech expert, Andrew R. Snyder, PhD. Jeffrey Snyder, Broadcast Retirement ...

Returning for its fourth year, Bisnow’s International Life Sciences & Biotech Conference returns to San Diego in September 2026, bringing together global leaders across biotechnology, real estate, ...

Imagine the perfect drink — a cocktail, coffee, or kombucha, perhaps. Whatever the concoction, it came together iteratively — one taste test, one tweak at a time. In much the same way, mixing ...

This is Gilead's third acquisition this year alone. At this point, M&A is less about growth and more about survival for the ...

Step inside Natasha Sheybani’s office at the University of Virginia, where she runs a bioengineering lab, and you’ll find a kaleidoscopic sea of sticky notes. She uses purple for ideas sparked by ...

When broken down, the word "biotechnology" can be separated into two parts: bio, which means life, and technology, which is the application of scientific knowledge for useful purposes. Therefore, ...

Gilead Sciences has agreed to buy German clinical-stage biotechnology company Tubulis for up to $5 billion in a deal that ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Innovation Quarter is ...

Learn how Portugal’s biotech and life sciences ecosystem is advancing research, startups, and innovation even amid funding ...